Accuracy of Immediate Implant Placement Using Robotic System Versus Dynamic Navigation System in Anterior Maxillae: a Random Controlled Clinical Trial
Launched by SHANGHAI NINTH PEOPLE'S HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for placing dental implants in the front part of the upper jaw (the maxilla). Specifically, it will compare a robotic system to a dynamic navigation system, which helps dentists place implants more accurately. The goal is to find out which method provides better accuracy, takes less time during surgery, and offers a better experience for patients.
To be eligible for this study, participants need to be at least 18 years old and in good health. They should have one or more upper front teeth that need to be removed but can’t be saved, and there should be enough healthy bone for the implant. However, people with certain health issues, a history of gum disease, or those who smoke heavily may not be able to participate. If you choose to join, you will receive a follow-up scan after surgery to check how well the implant was placed, and you’ll be monitored for a year to see how you’re doing overall. This trial is not yet recruiting participants but aims to improve dental implant procedures for better patient outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a. ≥18 years old and in good health; b. One or more maxillary incisors that cannot be retained due to non-periodontitis; c. The buccal bone plate is complete; d. No acute infection; e. The extraction socket have at least 3-5 mm apical bone.
- Exclusion Criteria:
- • a. General contraindications of oral implant surgery (such as immunodeficiency, long-term use of corticosteroids); b. Treatments or diseases that may affect bone tissue metabolism (for example, taking bisphosphonates or receiving local radiotherapy); c. Periodontitis history or uncontrolled periodontitis. Bleeding of probing (BOP) positive site ≥ 10%, or probing depth (PD) ≥ 4mm; d. Heavy smokers or previous heavy smoking history (quit smoking time \<5 years or\> 20 cigarettes per day); e. Refuse to participate in this trial.
About Shanghai Ninth People's Hospital Affiliated To Shanghai Jiao Tong University
Shanghai Ninth People's Hospital, affiliated with Shanghai Jiao Tong University, is a leading clinical research institution in China, renowned for its commitment to advancing medical science and improving patient care. As a prominent teaching hospital, it integrates high-quality clinical services, innovative research, and comprehensive medical education. The hospital is dedicated to conducting rigorous clinical trials across various medical fields, leveraging its state-of-the-art facilities and a multidisciplinary team of experts to foster the development of new therapies and contribute to global health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported